Author | Richard S. Finn, MD | OncLive

Author | Richard S. Finn, MD

Articles

Dr. Finn on Biomarkers of Response in HCC

March 12, 2020

Video

Richard S. Finn, MD, discusses biomarkers of response to immunotherapy in hepatocellular carcinoma.

Dr. Finn on the Rationale for the Phase III KEYNOTE-240 Trial in HCC

September 25, 2019

Video

Richard S. Finn, MD, professor of clinical medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles (UCLA), and Director of the Signal Transduction and Therapeutics Program at the Jonsson Comprehensive Cancer Center at UCLA, discusses the rationale for the phase III KEYNOTE-240 trial in hepatocellular carcinoma (HCC).

Dr. Finn Discusses Sequencing Therapy for HCC

August 07, 2018

Video

Richard S. Finn, MD, assistant professor of medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles, discusses sequencing therapy for patients with hepatocellular carcinoma.

Dr. Finn Recaps Second-Line Advancements in HCC

June 22, 2018

Video

Richard S. Finn, MD, assistant professor of medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles, recaps recent second-line advancements in hepatocellular carcinoma.

x